Why the Same Name “Stem Cell Conditioned Media” Can Actually Contain Very Different Substances — Dr. Moriwaki Organizes the 7 Manufacturing Steps That Create Stem Cell Conditioned Media Manufacturing Variability, and the Question List Patients Should Ask Their Physician in Hair Treatment2026.08.12

“Clinic A and Clinic B both use the same ‘stem cell conditioned media,’ yet the price is more than twice as different,” “I can’t really tell if the supernatant recommended for my hair treatment is truly the same product as the one I heard about at another clinic’s consultation” — these are questions we often receive at first visits for hair regenerative medicine.

In fact, even preparations lumped together as “stem cell conditioned media” have non-standardized cell sources, culture media, and manufacturing processes, and due to stem cell conditioned media manufacturing variability, the contents can end up being fundamentally different.

In this article, from the perspective of Dr. Moriwaki at AVAN TOKYO Ginza, we organize why stem cell conditioned media manufacturing variability arises, and the list of questions patients should ask their physician to see through product differences in hair treatment.

Key Points of This Article

・The term “stem cell conditioned media” is not a specific product name but rather a general designation covering products with non-standardized cell sources, culture media, and manufacturing processes.

・Stem cell conditioned media manufacturing variability arises across 7 steps: cell source / culture medium / passage number / harvest timing / concentration and purification / freeze-thaw / lot management.

・Food-industry or advertising-style words such as “additive-free,” “organic,” or “MHLW-approved” do not constitute a quality guarantee for supernatant.

・For patients, seeing through product differences starts with checking three points: the cell source, the manufacturing facility’s notification number, and whether the Certificate of Analysis (CoA) per lot can be disclosed.

・Price differences do not equal quality differences — advertising costs, shipping, and inventory turnover all shape the price at each clinic.

The Ambiguity Behind the Name “Stem Cell Conditioned Media”

The term “stem cell conditioned media” that you see in medical advertising or explanatory materials is not, in fact, a specific product name. It is closer to a collective noun that refers to “the general term for the components secreted into the culture medium when mesenchymal stem cells and similar cells are cultured for a certain period.”

Therefore, even if Clinic A and Clinic B both claim to use the same “stem cell conditioned media,” if the source cells, culture media, and manufacturing processes differ, the profile of growth factors, exosomes, and proteins contained will differ substantially. Stem cell conditioned media manufacturing variability is the structural background that produces this reality of “the same name but different substance.”

Where in the Manufacturing Process Does the “Substance” Vary?

Cell Source (Umbilical Cord, Adipose, Dental Pulp)

Depending on whether the source cells are derived from umbilical cord, adipose tissue, or dental pulp, the composition of secreted growth factors changes. Because the relative ratios of factors such as VEGF, IGF-1, HGF, and TGF-β differ, the theoretically expected clinical response also differs. A supernatant that does not clearly state its cellular origin cannot even be placed on the same field for comparison.

Culture Medium Composition and Presence of Serum

Whether the culture is serum-free, uses medium containing fetal bovine serum (FBS), or uses human platelet lysate (hPL), the profile of xenogeneic proteins and additives contained in the supernatant differs. The items to be checked in safety testing also change accordingly.

Passage Number and Harvest Timing

Cells change their secretory capacity as they undergo more passages. Depending on which passage is harvested and at which cell density, the composition of the supernatant varies. A manufacturer that does not manage this information has weak lot reproducibility to begin with.

Concentration, Purification, and Freeze-Thaw Steps

The design of purification steps such as ultrafiltration, centrifugation, and lyophilization, as well as the number of freeze-thaw cycles, affects the potency of growth factors. Including cold-chain management, stem cell conditioned media manufacturing variability opens up widely here.

Why “Product Differences” Become Hard to See in Hair Treatment

In hair regenerative medicine, supernatant is used by injecting it into the scalp or delivering it through drug-delivery devices. What makes this difficult is that it takes 3 to 6 months of the hair cycle before the patient can personally feel “whether it is working or not,” and that objective indicators such as photographs, hair diameter measurements, and trichoscopy must be aligned before results can be compared side by side.

In other words, it is realistically quite difficult for patients to see through product differences of the supernatant itself by “trying it out on their own scalp.” This is precisely why information disclosure before the procedure — and confirmation that goes into stem cell conditioned media manufacturing variability — becomes important.

The List of Questions Patients Should Ask Their Physician

・What is the cell source (umbilical cord, adipose, dental pulp, etc.) of the supernatant used?

・Is the manufacturing facility registered for “Specified Cell-Processed Product Manufacturing,” and can the notification number be shown?

・Can the per-lot CoA (Certificate of Analysis) be disclosed?

・What are the test items and specification values for sterility, mycoplasma, and endotoxin?

・How many freeze-thaw cycles have occurred, and how is the cold chain from transport to storage managed?

・What is the record of past administration and the reporting/response system for adverse events?

A physician or clinic that sincerely answers these six questions can be judged to be at least aware of stem cell conditioned media manufacturing variability and to have a framework for quality management. Conversely, if the answers end with “Details are trade secrets” or “Effects vary by individual,” there is room for cautious consideration. For how to read medical advertising and information literacy, related guidance from the Japanese Dermatological Association is also a helpful reference.

Why You Should Not Judge Stem Cell Conditioned Media Manufacturing Variability by “Price Difference”

“The more expensive the supernatant, the higher the quality” is a shortcut. Prices involve not only cost of goods and manufacturing management costs, but also multiple variables such as shipping, advertising expenses, inventory turnover, and each clinic’s profit design. Conversely, “cheap = shoddy” is not necessarily true.

The criteria for judgment are not price, but test data, the manufacturing facility’s notification, traceability, and — importantly — the physician’s attitude in explaining. For other related columns on hair treatment, please also see the list of related columns on hair regenerative medicine here.

Note that hair treatment using stem cell conditioned media has individual variation in effects and does not guarantee hair growth for every form of hair thinning. The principle is to share indications and limits with the physician and to design a realistic treatment plan.

Frequently Asked Questions

Q. If it says “stem cell conditioned media,” is the substance the same at every clinic?

No. Because the cell source, culture medium, and manufacturing process are non-standardized, the composition and quality can differ even under the same name. The name as a general designation and the reality of the individual product must be considered separately.

Q. To see through product differences, what should a patient ask first?

Please first confirm three points: “cell source,” “manufacturing facility’s notification number,” and “disclosure availability of the CoA (Certificate of Analysis).” Whether the clinic can sincerely answer these three points reveals part of its quality management stance.

Q. Is more expensive supernatant necessarily higher quality?

Not necessarily. Prices are shaped by many factors, including cost of goods, shipping, advertising expenses, and inventory turnover. Quality should be judged based on the CoA, test data, manufacturing facility’s notification, and traceability.

Q. How much does supernatant manufacturing variability affect the outcomes of hair treatment?

At the current level of clinical evidence, comparative trials quantitatively showing how much manufacturing variability affects the outcomes of hair treatment are scarce, and interactions with individual variation and treatment design are also large. That is precisely why prior information disclosure and objective post-procedure evaluation matter.

Q. Is supernatant labeled “additive-free” or “organic” safer?

Supernatant is a medical preparation, and food-industry terms like “additive-free” or “organic” do not constitute a quality guarantee. Please judge based on safety testing systems such as sterility, mycoplasma, and endotoxin testing, as well as manufacturing facility notification and traceability.

──────────────

Medical Supervision: Dr. Shin Moriwaki (Supervising Physician)

Member, Japan Society of Aesthetic Surgery (JSAS)

Member, American Academy of Aesthetic Medicine

ECFMG Certificate

──────────────

📍AVAN TOKYO Ginza Hair Regenerative Medicine

AVAN TOKYO Ginza Hair Regenerative Medicine

English / 中文 / Tiếng Việt supported

Inquiries welcome via DM / LINE / Website / Phone.